Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.

Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Abstract Text:

    t utsunomiyaT Utsunomiya,s yonezawaS Yonezawa,h sakamotoH Sakamoto,h kitamuraH Kitamura,s hokitaS Hokita,t aikoT Aiko,s tanakaS Tanaka,t irimuraT Irimura,y s kimY S Kim,e satoE Sato,

    Our previous immunohistochemical studies for the expression of MUC1 mucin antigen (which was detected by monoclonal antibody DF3) and MUC2 mucin antigen (which was detected by polyclonal antibody anti-MRP) in pancreatic and intrahepatic bile duct tumors demonstrated that invasive carcinoma with poor outcome showed a pattern of MUC1+ and MUC2- expression, whereas many of the noninvasive tumors with favorable outcome showed a pattern of MUC1- and MUC2+ expression. To clarify the relationship between the expression of these mucin antigens and the biological properties of gastric cancers, the expression of MUC1 and MUC2 mucin antigens was examined immunohistochemically in 136 patients with gastric cancer invading the submucosa or the deeper layer, and the survival of the antigen-positive and antigen-negative patient groups was compared using the Kaplan-Meier method. For MUC1 mucin expression, different glycoforms of MUC1 were examined using four monoclonal antibodies (NCL-MUC-1-CORE, DF3, MY.1E12, and HMFG-1). The patients with MUC1+ mucin antigen staining in the carcinoma showed significantly worse survival than those with MUC1- mucin antigen staining. In contrast, the patients with MUC2+ mucin antigen staining in the carcinoma showed significantly better survival than those with MUC2- mucin antigen staining. In conclusion, MUC1 antigen expression was associated with a poor outcome in patients with gastric cancer, irrespective of its glycosylation status, and MUC1 is thus considered to be a useful prognostic factor for poor outcome in patients. In contrast, MUC2 antigen expression is a prognostic factor associated with a favorable outcome in patients. In addition, combined evaluation of the MUC1 and MUC2 mucin staining is clinically useful to predict outcome in patients with gastric cancer.

    Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Publishing Authors By Initials

    t utsunomiyaT Utsunomiya,s yonezawaS Yonezawa,h sakamotoH Sakamoto,h kitamuraH Kitamura,s hokitaS Hokita,t aikoT Aiko,s tanakaS Tanaka,t irimuraT Irimura,ys kimYS Kim,e satoE Sato,

    For similar investigative techniques: epidemiologic methods: data collection: vital statistics: mortality: survival rate research abstracts see: investigative techniques: epidemiologic methods: data collection: vital statistics: mortality: survival rate research

    PUBMED ID PMID:

    MEDLINE DATE:

    Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: Clinical cancer research : an official journal of

    VOLUME: 4

    Page Numbers: 2605-14

    Journal Abbreviation: Clin. Cancer Res.

    ISSN: 1078-0432

    DAY: 30

    MONTH: Nov

    YEAR: 1998

    Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9502500

    Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Keywords Mesh Terms:

    KEYWORDS: Survival Rate

    MESH TERMS: physiopathology

    Chemical & Substance for Abstract: Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Information

    Substance Name: Mucins

    Registry Number: 0

    Grant and Affiliation Information for Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.

    AFFILIATION: Department of Pathology, Kagoshima University School of Medicine, Japan.

    Country: UNITED STATES

    UNITED STATES Research PublicationUNITED STATES Research Publication

    AGENCY: United States NCI

    GRANT: CA24321

    ACRONYM: CA

    MEDLINETA: Clin Cancer Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News